Show
Sort by
-
Completeness of reporting oligometastatic disease characteristics in literature and influence on oligometastatic disease classification using the ESTRO/EORTC nomenclature
-
The financial impact of SBRT for oligometastatic disease : a population-level analysis in Belgium
-
- Journal Article
- A1
- open access
Defining oligometastatic disease from a radiation oncology perspective : an ESTRO-ASTRO consensus document
-
- Journal Article
- A1
- open access
Study protocol for a randomized controlled trial : prophylactic swallowing exercises in head-and-neck cancer patients treated with (chemo)radiotherapy (PRESTO trial)
-
Dose de-escalation to the elective lymph nodes in head and neck cancer : in regard to Maguire et al
-
Correlation of patient- and physician-scored dysphagia with videofluoroscopies in patients treated with radiotherapy for head and neck cancer
-
Upfront vs. no upfront neck dissection in primary head and neck cancer radio(chemo) therapy : reply to Elicin et al.
-
Dose de-escalation to the elective lymph nodes in head and neck cancer : reply to Amdur et al.
-
Recurrence patterns after a decreased dose of 40 Gy to the elective treated neck in head and neck cancer
-
Validation of the total dysphagia risk score (TDRS) in head and neck cancer patients in a conventional and a partially accelerated radiotherapy scheme